Form D · Biotechnology
Palladio Biosciences, Inc.
Horsham, PA · CIK 0001827356
Offering snapshot reported Oct 7, 2020 · SEC filing
- Reported sold
- $28M Offering amount: $36.5M
- Investors reported
- 5 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- Sep 24, 2020 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| Oct 7, 2020 | Initial | $27,983,505 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity, Security to be acquired
- Exemptions
- 06b
- Duration over one year
- No
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-377324
Source: Form D, filed Oct 7, 2020. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Frank Condella | Director |
| Francesco De Rubertis | Director |
| John Alexander Martin | Director, Executive |
| Michele Ollier | Director |
| Lorenzo Pellegrini | Director, Executive |
| Marella Thorell | Executive |
| Sanford Zweifach | Director |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
5 Walnut Grove Drive, Suite 120
Horsham, PA, 19044
Horsham, PA, 19044